On January 12th, 2026, the Fondation Ildys announced the active recruitment phase for a clinical study evaluating the impact of the Breizh Fabribus intervention. The initiative focuses on creating or adapting personalized assistive technologies to support individuals facing amputation, functional limitations, or challenges related to autonomy in older adults. This marks a significant step forward in addressing critical patient needs through customization and innovation.
In this article:
What changed?
The Breizh Fabribus program, in collaboration with Fondation Ildys, has initiated active recruitment for participants. This is a pivotal milestone for the study, which is centered on delivering customized assistive technologies to address specific functional and autonomy limitations through innovative solutions. The study aims to refine approaches that could enhance quality of life and independence for diverse populations.
What are the study objectives?
The overarching objective of the study is to assess the impact of assistive technology personalization and adaptation. Through this evaluation, the research team intends to gather data on performance, safety, and user experience, aligning with Medical Device Regulation standards. Specific targets include:
- Improving mobility and independence for individuals with amputation or physical handicaps.
- Enhancing the autonomy of older adults facing functional limitations.
- Evaluating adaptation methods for broader population applicability.
Who is affected?
The study targets individuals impacted by amputation, physical limitations, and loss of autonomy due to age-related challenges. By focusing on these groups, the initiative seeks to address gaps in assistive technology availability and customization that are critical to patient outcomes.
Participants will experience firsthand how tailored technologies can meet their specific needs, providing insights that will influence the broader application of these interventions.
Frequently Asked Questions
- Who sponsors the study?
The study is sponsored by Fondation Ildys, a key stakeholder in advancing personalized health solutions. - Where can I find the official record?
The clinical trial is documented on ClinicalTrials.gov under the identifier NCT07314099. - Are participants currently being recruited?
Yes, recruitment is active, as confirmed in the January 2026 update. - What conditions are addressed?
The study addresses amputation, physical handicaps, functional limitations, and autonomy challenges in older adults.
Key takeaways
The Breizh Fabribus intervention represents a transformative approach to personalized assistive technology development. Early findings and recruitment efforts demonstrate a clear commitment to improving patient autonomy and quality of life. Interested professionals should monitor updates for insights into application models and regulatory implications.
Disclaimer
The content provided herein is for informational purposes only and does not constitute legal advice. For regulatory guidance, consult a qualified professional.
Full Announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07314099?term=medical+device